Endocrinology · Edina, MN
NPI
1093775736
Since 2006
Specialty
Endocrinology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
7701 York Ave S, Suite 180
Edina, MN, 55435
Phone (952) 927-7810
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
2,414 services
Medicare patients, 2024
390
Average age 74
Drug cost, 2024
$1.7M
4,229 prescriptions
Company payments, 2025
$334
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca S Mattison was code 36415 (venipuncture blood collection), 492 times for 337 patients. In total Rebecca S Mattison billed 2,414 services in 37 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 492 | 337 | $8.65 | $4,256 |
| 99214 Office E&M - Established | Office | 286 | 180 | $79.84 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 243 | 219 | $10.87 | $2,641 |
| 99213 Office E&M - Established | Office | 221 | 190 | $57.22 | $13K |
| 80048 Clinical Chemistry | Office | 201 | 143 | $8.29 | $1,666 |
| 83036 Blood Count | Office | 181 | 101 | $9.52 | $1,723 |
| 95251 Test - Miscellaneous | Office | 115 | 51 | $22.66 | $2,606 |
| 82565 Clinical Chemistry | Office | 110 | 103 | $5.02 | $552 |
| 82310 Clinical Chemistry | Office | 108 | 100 | $5.06 | $546 |
| 80061 Clinical Chemistry | Office | 78 | 68 | $13.12 | $1,023 |
| 84443 Clinical Chemistry | Office | 65 | 60 | $16.46 | $1,070 |
| 84439 Clinical Chemistry | Office | 62 | 57 | $8.84 | $548 |
| 82306 Clinical Chemistry | Office | 49 | 46 | $29.01 | $1,421 |
| 83970 Clinical Chemistry | Office | 37 | 33 | $40.45 | $1,497 |
| 99204 Office E&M - New | Office | 25 | 25 | $119.84 | $2,996 |
By year: 2022 $159K for 7,586 services; 2023 $64K for 2,251 services; 2024 $64K for 2,414 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 492 | 337 | $8.65 | $4,256 |
| 80048 Clinical Chemistry | 201 | 143 | $8.29 | $1,666 |
| 83036 Blood Count | 181 | 101 | $9.52 | $1,723 |
| 82565 Clinical Chemistry | 110 | 103 | $5.02 | $552 |
| 82310 Clinical Chemistry | 108 | 100 | $5.06 | $546 |
| 80061 Clinical Chemistry | 78 | 68 | $13.12 | $1,023 |
| 84443 Clinical Chemistry | 65 | 60 | $16.46 | $1,070 |
| 84439 Clinical Chemistry | 62 | 57 | $8.84 | $548 |
| 82306 Clinical Chemistry | 49 | 46 | $29.01 | $1,421 |
| 83970 Clinical Chemistry | 37 | 33 | $40.45 | $1,497 |
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca S Mattison prescribed most often to Medicare patients was Levothyroxine Sodium, with 964 prescriptions and refills. In total Rebecca S Mattison wrote 4,229 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 964 | 2,640 | 260 | $18K |
| Alendronate Sodium Generic | 314 | 833 | 93 | $4,156 |
| Synthroid Levothyroxine Sodium | 206 | 523 | 53 | $19K |
| Metformin Hcl Er Metformin Hcl | 150 | 403 | 45 | $2,689 |
| Ozempic Semaglutide | 121 | 185 | 24 | $174K |
| Metformin Hcl Generic | 114 | 289 | 30 | $1,795 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 111 | 300 | 40 | $20K |
| Mounjaro Tirzepatide | 96 | 126 | 17 | $133K |
| Teriparatide Generic | 89 | 93 | 11 | $227K |
| Methimazole Generic | 84 | 226 | 23 | $1,122 |
| Jardiance Empagliflozin | 71 | 153 | 18 | $83K |
| Liothyronine Sodium Generic | 71 | 191 | 19 | $4,356 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 70 | 193 | 32 | $8,610 |
| Rosuvastatin Calcium Generic | 69 | 197 | 20 | $1,073 |
| Simvastatin Generic | 66 | 172 | 19 | $917 |
Brand drugs: 2,030 claims; generic drugs: 1,869 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca S Mattison $334 ($334 in general payments such as food, travel and fees) from 14 companies. The largest payer was Recordati_rare_diseases_inc. with $60.17.
| Company | Payments | Amount |
|---|---|---|
| Recordati_rare_diseases_inc. | 3 | $60.17 |
| Insulet Corporation PODD | 2 | $40.63 |
| Pfizer Inc. PFE | 2 | $34.84 |
| Medtronic, Inc. MDT | 1 | $24.26 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $22.54 |
| Mannkind Corporation MNKD | 1 | $20.85 |
| Abbott Laboratories ABT | 1 | $18.83 |
| Chiesi USA, Inc. | 1 | $18.26 |
| Ionis Pharmaceuticals, Inc. IONS | 1 | $17.27 |
| CeQur Corporation | 1 | $16.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.